45
Participants
Start Date
May 7, 2025
Primary Completion Date
May 1, 2027
Study Completion Date
May 1, 2028
INM176
The active ingredient INM176 was prepared using a proprietary technology to extract AGN with ethanol and powderize with cellulose into a finished granular powder product that is 1/5 the weight of the raw herbal root. This product was chosen because its close match with the AGN extracts studied in the TRAMP model in the phytochemical profiles. It will be donated from the manufacturer Nutragen Co., Ltd. Korea.
RECRUITING
Penn State Cancer Institute, Hershey
Milton S. Hershey Medical Center
OTHER